Substantial Price Reduction Required for Asthma Treatment Mepolizumab to Meet Willingness-to-Pay Thresholds HCP Live, 28 Jul 2016 Although severe asthma affects less than 10% of asthma patients, it is marked by recurrent, critical exacerbations that pose…